Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean society of gynecologic oncology, Korean society of obstetrics and gynecology, and Korean society of gynecologic endoscopy and minimally invasive surgery position statement

Miseon Kim, Tae Wook Kong, Sunghoon Kim, Seung Cheol Kim, Yong Beom Kim, Jae Weon Kim, Jeong Yeol Park, Dong Hoon Suh, Seung Hyuk Shim, Keun Ho Lee, Sung Jong Lee, Jae Kwan Lee, Myong Cheol Lim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

On the basis of emerging data and the current understanding of minimally invasive surgery (MIS) for radical hysterectomy (RH) in women with cervical cancer, the Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery support the following recommendations: • According to the recently published phase III Laparoscopic Approach to Cervical Cancer (LACC) trial—a prospective randomized clinical trial—disease-free survival and overall survival rates of MIS RH are significantly lower than those of open RH. • Gynecologic oncologists should be aware of the emerging data on MIS RH for early-stage cervical cancer. • The results of the LACC trial, together with institutional data, should be discussed with patients before choosing MIS RH. • MIS RH should be performed for optimal candidates according to the current practice guidelines by gynecologic oncologists who are skilled at performing MIS.

Original languageEnglish
Article numbere104
JournalJournal of gynecologic oncology
Volume30
Issue number5
DOIs
Publication statusPublished - 2019 Sep

Fingerprint

Minimally Invasive Surgical Procedures
Hysterectomy
Gynecology
Uterine Cervical Neoplasms
Endoscopy
Obstetrics
Practice Guidelines
Survival Rate
Survival

Keywords

  • Hysterectomy
  • Laparoscopy
  • Laparotomy
  • Minimally Invasive Surgical Procedures
  • Uterine Cervical Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Minimally invasive surgery for radical hysterectomy in women with cervical cancer : Korean society of gynecologic oncology, Korean society of obstetrics and gynecology, and Korean society of gynecologic endoscopy and minimally invasive surgery position statement. / Kim, Miseon; Kong, Tae Wook; Kim, Sunghoon; Kim, Seung Cheol; Kim, Yong Beom; Kim, Jae Weon; Park, Jeong Yeol; Suh, Dong Hoon; Shim, Seung Hyuk; Lee, Keun Ho; Lee, Sung Jong; Lee, Jae Kwan; Lim, Myong Cheol.

In: Journal of gynecologic oncology, Vol. 30, No. 5, e104, 09.2019.

Research output: Contribution to journalArticle

Kim, Miseon ; Kong, Tae Wook ; Kim, Sunghoon ; Kim, Seung Cheol ; Kim, Yong Beom ; Kim, Jae Weon ; Park, Jeong Yeol ; Suh, Dong Hoon ; Shim, Seung Hyuk ; Lee, Keun Ho ; Lee, Sung Jong ; Lee, Jae Kwan ; Lim, Myong Cheol. / Minimally invasive surgery for radical hysterectomy in women with cervical cancer : Korean society of gynecologic oncology, Korean society of obstetrics and gynecology, and Korean society of gynecologic endoscopy and minimally invasive surgery position statement. In: Journal of gynecologic oncology. 2019 ; Vol. 30, No. 5.
@article{e428e94b3f8540628dc2257e1d1637c3,
title = "Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean society of gynecologic oncology, Korean society of obstetrics and gynecology, and Korean society of gynecologic endoscopy and minimally invasive surgery position statement",
abstract = "On the basis of emerging data and the current understanding of minimally invasive surgery (MIS) for radical hysterectomy (RH) in women with cervical cancer, the Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery support the following recommendations: • According to the recently published phase III Laparoscopic Approach to Cervical Cancer (LACC) trial—a prospective randomized clinical trial—disease-free survival and overall survival rates of MIS RH are significantly lower than those of open RH. • Gynecologic oncologists should be aware of the emerging data on MIS RH for early-stage cervical cancer. • The results of the LACC trial, together with institutional data, should be discussed with patients before choosing MIS RH. • MIS RH should be performed for optimal candidates according to the current practice guidelines by gynecologic oncologists who are skilled at performing MIS.",
keywords = "Hysterectomy, Laparoscopy, Laparotomy, Minimally Invasive Surgical Procedures, Uterine Cervical Neoplasms",
author = "Miseon Kim and Kong, {Tae Wook} and Sunghoon Kim and Kim, {Seung Cheol} and Kim, {Yong Beom} and Kim, {Jae Weon} and Park, {Jeong Yeol} and Suh, {Dong Hoon} and Shim, {Seung Hyuk} and Lee, {Keun Ho} and Lee, {Sung Jong} and Lee, {Jae Kwan} and Lim, {Myong Cheol}",
year = "2019",
month = "9",
doi = "10.3802/jgo.2019.30.e104",
language = "English",
volume = "30",
journal = "Journal of Gynecologic Oncology",
issn = "2005-0380",
publisher = "Korean Society of Gynecologic Oncology and Colposcopy",
number = "5",

}

TY - JOUR

T1 - Minimally invasive surgery for radical hysterectomy in women with cervical cancer

T2 - Korean society of gynecologic oncology, Korean society of obstetrics and gynecology, and Korean society of gynecologic endoscopy and minimally invasive surgery position statement

AU - Kim, Miseon

AU - Kong, Tae Wook

AU - Kim, Sunghoon

AU - Kim, Seung Cheol

AU - Kim, Yong Beom

AU - Kim, Jae Weon

AU - Park, Jeong Yeol

AU - Suh, Dong Hoon

AU - Shim, Seung Hyuk

AU - Lee, Keun Ho

AU - Lee, Sung Jong

AU - Lee, Jae Kwan

AU - Lim, Myong Cheol

PY - 2019/9

Y1 - 2019/9

N2 - On the basis of emerging data and the current understanding of minimally invasive surgery (MIS) for radical hysterectomy (RH) in women with cervical cancer, the Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery support the following recommendations: • According to the recently published phase III Laparoscopic Approach to Cervical Cancer (LACC) trial—a prospective randomized clinical trial—disease-free survival and overall survival rates of MIS RH are significantly lower than those of open RH. • Gynecologic oncologists should be aware of the emerging data on MIS RH for early-stage cervical cancer. • The results of the LACC trial, together with institutional data, should be discussed with patients before choosing MIS RH. • MIS RH should be performed for optimal candidates according to the current practice guidelines by gynecologic oncologists who are skilled at performing MIS.

AB - On the basis of emerging data and the current understanding of minimally invasive surgery (MIS) for radical hysterectomy (RH) in women with cervical cancer, the Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery support the following recommendations: • According to the recently published phase III Laparoscopic Approach to Cervical Cancer (LACC) trial—a prospective randomized clinical trial—disease-free survival and overall survival rates of MIS RH are significantly lower than those of open RH. • Gynecologic oncologists should be aware of the emerging data on MIS RH for early-stage cervical cancer. • The results of the LACC trial, together with institutional data, should be discussed with patients before choosing MIS RH. • MIS RH should be performed for optimal candidates according to the current practice guidelines by gynecologic oncologists who are skilled at performing MIS.

KW - Hysterectomy

KW - Laparoscopy

KW - Laparotomy

KW - Minimally Invasive Surgical Procedures

KW - Uterine Cervical Neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85073284156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073284156&partnerID=8YFLogxK

U2 - 10.3802/jgo.2019.30.e104

DO - 10.3802/jgo.2019.30.e104

M3 - Article

C2 - 31328466

AN - SCOPUS:85073284156

VL - 30

JO - Journal of Gynecologic Oncology

JF - Journal of Gynecologic Oncology

SN - 2005-0380

IS - 5

M1 - e104

ER -